Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Bermudez LE and Young LS |
Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2847644
|
Yourassowsky E et al. |
Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid. |
1988 |
Chemotherapy |
pmid:2843324
|
Retsema J et al. |
Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2449865
|
Girard AE et al. |
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2830841
|
Walsh M et al. |
In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:3038010
|
Veskitkul J et al. |
Recurrent Acute Rhinosinusitis Prevention by Azithromycin in Children with Nonallergic Rhinitis. |
|
J Allergy Clin Immunol Pract |
pmid:28438539
|
MartÃn-Pozo A et al. |
[Susceptibility to azithromycin and other antibiotics in recent isolates of Salmonella, Shigella and Yersinia]. |
|
Enferm. Infecc. Microbiol. Clin. |
pmid:24698008
|
|
|
|
|
pmid:
|
Osman EY et al. |
Analysis of Azithromycin Monohydrate as a Single or a Combinatorial Therapy in a Mouse Model of Severe Spinal Muscular Atrophy. |
|
J Neuromuscul Dis |
pmid:28598854
|